2021 EAEU regulatory changes
January 15, 2021
January 15, 2021
2021 EAEU regulatory changes
Are you ready for 2021 EAEU regulatory changes?
Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).
For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.
If you want to find out more information about EAEU registration rules, please contact us at info@inpharmatis.com.
Webinar: EAEU Regulatory Challenges and Opportunities
November 09, 2020
Readability user testing is requested in EAEU
October 15, 2020
Inpharmatis & Epista Partnership Announcement
September 03, 2020
User Testing Instructions Webinar on 30 April in Russian
April 27, 2020
Inpharmatis Team COVID-19 Update
March 30, 2020
Inpharmatis - Winner in EU GMP Inspection Tender
March 19, 2020
Bебинар: Регистрация и создание досье в электронном формате по новым стандартам ЕАЭС
December 09, 2019
The EAEU Electronic Submission Format
November 20, 2019
Meet us at IV All-Russia GMP Conference 2019
September 23, 2019